ICICI Direct recommended hold rating on Aurobindo Pharma with a target price of Rs 540 in its research report dated November 14, 2022.
ICICI Direct recommended hold rating on Aurobindo Pharma with a target price of Rs 540 in its research report dated November 14, 2022.